The Elmet Group Co. (ELMT) Stock Price & How to Invest

The Elmet Group makes things out of metals that almost nothing else survives. Its Critical Materials Components division machines tungsten, molybdenum, niobium and tantalum into precision parts that hold their shape at temperatures where steel fails: armor and penetrator components, X-ray targets for medical imaging, hot-zone and thermal hardware for semiconductor tools, and parts feeding programs including Patriot, Phalanx, JDAM and the F-35. Its smaller Engineered Microwave Products division builds custom high-power microwave and RF energy systems for industrial heating, research and accelerator work. The company traces its roots to 1929, runs more than 500,000 square feet across Lewiston in Maine, Coldwater in Michigan and Euclid in Ohio, employs roughly 530 people, and describes itself as the only US-owned and US-based manufacturer of highly engineered tungsten and molybdenum products.

The investment picture changed twice in five months. Elmet came public the conventional way, pricing 8.6 million shares at $14 on April 22, 2026 for about $125 million net, and it retired most of its debt with the proceeds. That left a company with roughly $228 million of trailing revenue, a record ~$132 million backlog, about $66 million of cash against ~$11 million of debt at the end of Q2 (Yahoo Finance now shows about $71 million of cash and $23 million of total debt), and only two reported quarters of public operating history. Then on September 14, 2026 the Department of War committed $450 million through redeemable preferred equity plus warrants for up to 19.9% of the common stock, and the Defense Logistics Agency handed Elmet Technologies an IDIQ contract with a $2 billion ceiling to help rebuild the National Defense Stockpile. The stock rose about 33% that session. A run of supply deals followed within three weeks: a long-term tungsten offtake with Tungsten West (September 22), an investment of about $125 million for a 4.99% stake in Vietnam's Masan High-Tech Materials (September 24), and a $36 million Defense Logistics Agency contract for molybdenum and tungsten aerospace materials (September 30). As of October 16, 2026 the shares closed at $19.48, about 15% below where they were a month earlier but roughly 39% above the $14 IPO price, for a market cap near $593 million. What the market is now weighing is a manufacturer with modest absolute earnings that has been handed the capital, the offtake and the mandate to integrate backward into tungsten mining and refining, a business it has never run.

Dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it around October 20, 2026, days from now. Only 8.6 million of roughly 30.5 million shares were sold in the IPO, so the float is thin and the price moves hard on news in both directions. Execution risk is a genuine step change rather than an extension: restarting a Nevada mine in late 2027 and an APT conversion plant in 2028 is a different business from machining refractory parts, and the schedule is years out. Reported growth flatters the underlying volume, since roughly 45% of Q2's increase came from raw material price pass-through, which reverses if tungsten prices fall back. The company also posted a GAAP net loss of ~$4.5 million in Q2 on ~$14.2 million of equity compensation, carries real customer concentration (medical backlog fell from ~$12 million to ~$5.5 million on one large customer's ordering pattern), and the stock has already given back about 15% of its value over the past month. The four covering analysts carry an average target of about $25, so expectations are high relative to an EV/EBITDA multiple near 49x on Yahoo's trailing figures. Spending about $125 million on a Masan stake and committing roughly $300 million to mining partners also stretches management attention across four continents.

4 analysts publish price targets on ELMT, averaging $25.00 against a $18.93 price as of October 2026, or +32.1%. The published targets run from $20.00 to $28.00, a moderate spread, and the ratings split 4 buy, 0 hold, 0 sell. Over the last six months there have been 5 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ELMT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on The Elmet Group Co.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Federal capital and a stockpile offtake, at the same time. The September 14 package pairs money with demand. The most optimistic published target, $28.00, assumes this works close to its best case.

The case against. Dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it around October 20, 2026, days from now. The most pessimistic target, $20.00, is roughly what ELMT is worth if this bites instead.

Read the full bull and bear case on ELMT, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see The Elmet Group Co.'s investor relations page or your broker.

• Revenue (TTM): ~$229M; latest quarter up ~35% YoY
• Q2 2026 revenue: ~$66M; gross margin ~25%
• Net income (TTM): ~-$3M GAAP (EPS ~-$0.40); adjusted Q2 EPS $0.18 vs ~$0.06 est.
• Gross / operating margin (TTM): ~23% / ~-11%
• Backlog / balance sheet: Backlog ~$132M (Q2); cash ~$71M against total debt ~$23M
• Market cap: ~$593M at $19.48
• Valuation multiples: ~2.6x sales; ~34x forward EPS; EV/EBITDA ~49x

The GAAP loss is mostly an IPO artifact: Q2 carried ~$14.2 million of equity compensation, of which ~$12.9 million was a one-time award vesting on the offering, so adjusted and reported figures diverge sharply and will keep doing so until the comparison laps. At about 34x forward earnings (consensus 2027 EPS ~$0.58) and roughly 2.6x sales, the stock is priced well above a typical fabricator, and the gap is the market's estimate of what the tungsten build-out is worth. None of the trailing figures include the Department of War capital, the stockpile contract, the Masan stake or the German acquisition, all announced after the July 3 quarter end; the November 16 report will be the first to reflect any of them.

Other names that sit close to ELMT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ELMT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so ELMT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ELMT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

ELMT is a government-backed critical-minerals industrial whose reported growth is real but partly a raw-material pass-through, and whose ~$593 million valuation (October 16, 2026) prices the tungsten build-out well ahead of the machine shop that actually earns the revenue.

Whether ELMT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ELMT a buy or a sell?, and where the stock could go from here in the ELMT stock forecast.

For income investors, whether ELMT pays a dividend and how the payout looks is covered in does ELMT pay a dividend? And to weigh ELMT against a peer, read the full side-by-side comparisons: ELMT vs RF and ELMT vs MP.